These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37765118)

  • 1. A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023.
    Ipe RS; Kumar S; Benny F; Jayan J; Manoharan A; Sudevan ST; George G; Gahtori P; Kim H; Mathew B
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
    Duarte P; Cuadrado A; León R
    Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
    Manzoor S; Hoda N
    Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of β-carboline and its derivatives as selective MAO-A inhibitors.
    Benny F; Kumar S; Jayan J; Abdelgawad MA; Ghoneim MM; Kumar A; Manoharan A; Susan R; Sudevan ST; Mathew B
    Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300091. PubMed ID: 37021551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease.
    Özdemir Z; Alagöz MA; Bahçecioğlu ÖF; Gök S
    Curr Med Chem; 2021; 28(29):6045-6065. PubMed ID: 33538661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
    Bhawna ; Kumar A; Bhatia M; Kapoor A; Kumar P; Kumar S
    Eur J Med Chem; 2022 Nov; 242():114655. PubMed ID: 36037788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.
    Lv Y; Zheng Z; Liu R; Guo J; Zhang C; Xie Y
    Int J Biol Macromol; 2023 Nov; 251():126158. PubMed ID: 37549764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected chromone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.
    Cruz-Monteagudo M; Borges F; Cordeiro MNDS; Helguera AM; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Perera-Sardina Y; Perez-Castillo Y
    Curr Neuropharmacol; 2017 Nov; 15(8):1117-1135. PubMed ID: 28093976
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ayaz M; Wadood A; Sadiq A; Ullah F; Anichkina O; Ghufran M
    J Biomol Struct Dyn; 2022; 40(20):10230-10238. PubMed ID: 34157942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneously Detecting Monoamine Oxidase A and B in Disease Cell/Tissue Samples Using Paper-Based Devices.
    Fang H; Wu M; Ji W; Wang L; Chen Y; Chen D; Yang N; Wu Q; Yu C; Liu J; Liu J; Bai H; Peng B; Huang X; Yu HD; Li L
    ACS Appl Bio Mater; 2021 Feb; 4(2):1395-1402. PubMed ID: 35014490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 3, 6-disubstituted isobenzofuran-1(3H)-ones as novel inhibitors of monoamine oxidases.
    Liu K; Zhou S; Zhou J; Bo R; Wang X; Xu T; Yuan Y; Xu B
    Bioorg Med Chem Lett; 2022 Jul; 67():128748. PubMed ID: 35472505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
    Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
    Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.
    Youdim MBH
    J Neural Transm (Vienna); 2018 Nov; 125(11):1719-1733. PubMed ID: 30341696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties.
    Reis J; Fernandes C; Salem H; Maia M; Tomé C; Benfeito S; Teixeira J; Oliveira PJ; Uriarte E; Ortuso F; Alcaro S; Bagetta D; Cagide F; Borges F
    Eur J Med Chem; 2022 Sep; 239():114507. PubMed ID: 35772321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.
    Ramsay RR; Majekova M; Medina M; Valoti M
    Front Neurosci; 2016; 10():375. PubMed ID: 27597816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.